MEDICO vs PGHL: Stock Comparison

MEDICO REMEDIES vs PROCTER & GAMBLE HEALTH LUpdated 4 Sept 26, 4:08 PM ISTNSE & company filings

PROCTER & GAMBLE HEALTH L is the larger company by market capitalisation. MEDICO REMEDIES shows faster revenue growth, while PROCTER & GAMBLE HEALTH L shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

MEDICO leads 3; PGHL leads 10 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

MEDICOPGHL

Valuation lens

What price are you paying?

Market CapContext only
₹329 Cr
₹9,379 Cr
P/E RatioPGHL has the lower reading
26.66x
26.43x
P/B RatioMEDICO has the lower reading
4.86x
17.98x
EPSPGHL has the higher reading
₹0.3
₹57.92
Book ValueContext only
₹9.1
₹316.01
Dividend YieldPGHL has the higher reading
0%
3.45%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
PGHL is the larger company
₹9,379 Cr vs ₹329 Cr
P/E Ratio
PGHL has a lower P/E
26.43x vs 26.66x
P/B Ratio
MEDICO has a lower P/B
4.86x vs 17.98x
EPS
PGHL has higher earnings per share
₹57.92 vs ₹0.3
Dividend Yield
PGHL has a higher dividend yield
3.45% vs 0%
Revenue Growth (TTM YoY)
MEDICO has faster revenue growth
37.5% vs 19.1%
EPS Growth (TTM YoY)
PGHL has faster EPS growth
54.6% vs 36.5%
Qtr Sales Growth
MEDICO has stronger quarterly sales growth
-66.37% vs -74.17%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricMEDICOPGHL
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricMEDICOPGHL
Live Price₹39.87₹5,660
Day Change0.94%-1.69%
Volume52,9327,255
52-Week High₹56.88₹6,975
52-Week Low₹30.22₹4,707
Distance from 52W High-29.91%-18.85%

Valuation

MetricMEDICOPGHL
Market Cap₹329 Cr₹9,379 Cr
P/E Ratio26.66x26.43x
P/B Ratio4.86x17.98x
EPS₹0.3₹57.92
Book Value₹9.1₹316.01
Dividend Yield0%3.45%

Growth

MetricMEDICOPGHL
Revenue Growth (TTM YoY)37.5%19.1%
EPS Growth (TTM YoY)36.5%54.6%
Qtr Sales Growth-66.37%-74.17%
Qtr Profit Growth-80.8%-70.59%

Profitability & Leverage

MetricMEDICOPGHL
ROE17.38%62.32%
ROCE15.61%92.1%
Net Margin6.36%23.22%
Operating Margin9.63%31.99%
Debt to Equity0.25x0x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricMEDICOPGHL
Promoter Holding61.38%0%
FII Holding0.08% 0.05 pp6.33% 0.13 pp
DII Holding0%12.44% 1.23 pp
Public Holding38.54% 0.05 pp29.42% 1.11 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: MEDICO REMEDIES and PROCTER & GAMBLE HEALTH L.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.